Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance
LAKE FOREST, Ill. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio” or “The Company”) (NASDAQ: ASRT), today announced the closing of its previously disclosed agreement (“Agreement”) with Alvogen , a global privately held pharmaceutical company, under which Alvogen will
Toggle Summary Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million
LAKE FOREST, Ill. , Dec. 12, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio”) (NASDAQ: ASRT), today announced it has entered into an agreement with Alvogen , a global privately held pharmaceutical company, under which Alvogen will acquire and assume all responsibilities associated
Toggle Summary Assertio Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
LAKE FOREST, Ill. , Nov. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 31 st Annual Piper Jaffray Healthcare Conference in a session scheduled for 9:30 a.m.

Upcoming Events

There are currently no events to display.

Recent SEC Filings

Filing date Description Form Filing Group View

Amendment to a previously filed 8-K

8-K/A
Current Reports
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

An amendment to the SC 13G filing

SC 13G/A
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

investor@assertiotx.com